Source:http://linkedlifedata.com/resource/umls/id/C0001034
CSP: hepatic carcinogen whose mechanism of activation involves N-hydroxylation to the arylhydroxamic acid followed by enzymatic sulfonation to sulfoxyfluorenylacetamide; used to study the carcinogenicity and mutagenicity of aromatic amines.